Skip to main content
Clinical Trials/CTRI/2021/10/037036
CTRI/2021/10/037036
Not yet recruiting
未知

A prospective, non-randomised observational study to identify immunological and inflammatory response of the host immune genes to Covid-19 infection.

Cancyte Technologies Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Cancyte Technologies Private Limited
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Cancyte Technologies Private Limited

Eligibility Criteria

Inclusion Criteria

  • All patients who can read and understand English and given their informed consent
  • gave Informed Consent for the study
  • Covid\-19 RT\-PCR positive patients
  • Non\-Vaccinated , Non\-infected , asymptomatic and symptomatic volunteers \- (Control Group)

Exclusion Criteria

  • Patient who have not given consent for this study
  • People with the history of Cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials